| Pharmaceutical active ingredients: |
| Cinnarizine |
| Available forms, composition and doses of Stugeron Forte: |
| Capsules; Oral; Cinnarizine 75 mgTablets; Oral; Cinnarizine 75 mg |
| Stugeron Forte medical category: |
| Human:Antivertigo drugsPeripheral vasodilators and cerebral activators |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07CA02 - Cinnarizine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| JanssenJohnson & JohnsonZuellig Pharma |